TrialDiabetes, obesity & metabolism2013

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.

K Stenlöf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.